Abstract
Tyrosine hydroxylase, the rate‐limiting enzyme in catecholamine biosynthesis, is activated following phosphorylation by the cAMP‐dependent protein kinase (largely by decreasing the Km of the enzyme for its pterin co‐substrate). Following its phosphorylation activation in rat striatal homogenates, we find that tyrosine hydroxylase is inactivated by two distinct processes. Because cAMP is hydrolyzed in crude extracts by a phospho‐diesterase, cAMP‐dependent protein kinase activity declines following a single addition of cAMP. When tyrosine hydroxylase is activated under these transient phosphorylation conditions, inactivation is accompanied by a reversion of the activated kinetic form (low apparent Km for pterin co‐substrate, ≤0.2 mM) to the kinetic form characteristic of the untreated enzyme (high apparent Km, ≥1.0 mM). This inactivation is readily reversed by the subsequent addition of cAMP. When striatal tyrosine hydroxylase is activated under constant phosphorylation conditions (incubated with purified cAMP‐dependent protein kinase catalytic subunit), however, it is also inactivated. This second inactivation process is irreversible and is characterized kinetically by a decreasing apparent Vmax with no change in the low apparent Km for pterin co‐substrate (0.2 mM). The latter inactivation process is greatly attenuated by gel filtration which resolves a low‐molecular‐weight inactivating factor(s) from the tyrosine hydroxylase. These results are consistent with a regulatory mechanism for tyrosine hydroxylase involving two processes: in the first case, reversible phosphorylaton and dephos‐phorylation and, in the second case, an irreversible loss of activity of the phosphorylated form of tyrosine hydroxylase.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 1692-1700 |
| Number of pages | 9 |
| Journal | Journal of Neurochemistry |
| Volume | 40 |
| Issue number | 6 |
| DOIs | |
| State | Published - Jan 1 1983 |
Fingerprint
All Science Journal Classification (ASJC) codes
- Biochemistry
- Cellular and Molecular Neuroscience
Cite this
}
Tyrosine Hydroxylase Inactivation Following cAMP‐Dependent Phosphorylation Activation. / Vrana, Kent; Roskoski, Robert.
In: Journal of Neurochemistry, Vol. 40, No. 6, 01.01.1983, p. 1692-1700.Research output: Contribution to journal › Article
TY - JOUR
T1 - Tyrosine Hydroxylase Inactivation Following cAMP‐Dependent Phosphorylation Activation
AU - Vrana, Kent
AU - Roskoski, Robert
PY - 1983/1/1
Y1 - 1983/1/1
N2 - Tyrosine hydroxylase, the rate‐limiting enzyme in catecholamine biosynthesis, is activated following phosphorylation by the cAMP‐dependent protein kinase (largely by decreasing the Km of the enzyme for its pterin co‐substrate). Following its phosphorylation activation in rat striatal homogenates, we find that tyrosine hydroxylase is inactivated by two distinct processes. Because cAMP is hydrolyzed in crude extracts by a phospho‐diesterase, cAMP‐dependent protein kinase activity declines following a single addition of cAMP. When tyrosine hydroxylase is activated under these transient phosphorylation conditions, inactivation is accompanied by a reversion of the activated kinetic form (low apparent Km for pterin co‐substrate, ≤0.2 mM) to the kinetic form characteristic of the untreated enzyme (high apparent Km, ≥1.0 mM). This inactivation is readily reversed by the subsequent addition of cAMP. When striatal tyrosine hydroxylase is activated under constant phosphorylation conditions (incubated with purified cAMP‐dependent protein kinase catalytic subunit), however, it is also inactivated. This second inactivation process is irreversible and is characterized kinetically by a decreasing apparent Vmax with no change in the low apparent Km for pterin co‐substrate (0.2 mM). The latter inactivation process is greatly attenuated by gel filtration which resolves a low‐molecular‐weight inactivating factor(s) from the tyrosine hydroxylase. These results are consistent with a regulatory mechanism for tyrosine hydroxylase involving two processes: in the first case, reversible phosphorylaton and dephos‐phorylation and, in the second case, an irreversible loss of activity of the phosphorylated form of tyrosine hydroxylase.
AB - Tyrosine hydroxylase, the rate‐limiting enzyme in catecholamine biosynthesis, is activated following phosphorylation by the cAMP‐dependent protein kinase (largely by decreasing the Km of the enzyme for its pterin co‐substrate). Following its phosphorylation activation in rat striatal homogenates, we find that tyrosine hydroxylase is inactivated by two distinct processes. Because cAMP is hydrolyzed in crude extracts by a phospho‐diesterase, cAMP‐dependent protein kinase activity declines following a single addition of cAMP. When tyrosine hydroxylase is activated under these transient phosphorylation conditions, inactivation is accompanied by a reversion of the activated kinetic form (low apparent Km for pterin co‐substrate, ≤0.2 mM) to the kinetic form characteristic of the untreated enzyme (high apparent Km, ≥1.0 mM). This inactivation is readily reversed by the subsequent addition of cAMP. When striatal tyrosine hydroxylase is activated under constant phosphorylation conditions (incubated with purified cAMP‐dependent protein kinase catalytic subunit), however, it is also inactivated. This second inactivation process is irreversible and is characterized kinetically by a decreasing apparent Vmax with no change in the low apparent Km for pterin co‐substrate (0.2 mM). The latter inactivation process is greatly attenuated by gel filtration which resolves a low‐molecular‐weight inactivating factor(s) from the tyrosine hydroxylase. These results are consistent with a regulatory mechanism for tyrosine hydroxylase involving two processes: in the first case, reversible phosphorylaton and dephos‐phorylation and, in the second case, an irreversible loss of activity of the phosphorylated form of tyrosine hydroxylase.
UR - http://www.scopus.com/inward/record.url?scp=0020586567&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0020586567&partnerID=8YFLogxK
U2 - 10.1111/j.1471-4159.1983.tb08144.x
DO - 10.1111/j.1471-4159.1983.tb08144.x
M3 - Article
C2 - 6133915
AN - SCOPUS:0020586567
VL - 40
SP - 1692
EP - 1700
JO - Journal of Neurochemistry
JF - Journal of Neurochemistry
SN - 0022-3042
IS - 6
ER -